Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07497932

Nutritional Effects in Cardiovascular Surgery

Nutritional Intervention in the Modulation of Postoperative Metabolism in Cardiovascular Surgery

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Fu Jen Catholic University · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the distribution of gut microbiota-derived metabolites, and to evaluate whether postoperative nutritional intervention can modulate the gut-heart metabolic axis, thereby improving metabolic profiles and clinical outcomes.

Detailed description

Background: Cardiovascular diseases remain the leading cause of mortality worldwide. Recent research has highlighted the role of gut microbiota and its metabolites-such as trimethylamine-N-oxide, phenylacetylglutamine, and p-cresyl sulfate-in the pathogenesis of cardiovascular disease through mechanisms involving inflammation, oxidative stress, and vascular dysfunction. However, little is known about the actual distribution of these metabolites in human cardiac tissues or their correlation with circulating levels. No clinical studies to date have systematically examined both tissue and blood samples in this context. Methods: Preoperative blood samples and intraoperative cardiac tissue specimens will be collected. Both targeted and untargeted metabolomics analyses will be performed using mass spectrometry to detect key gut microbiota-derived metabolites. A subset of patients will receive postoperative probiotic supplementation. Serial blood will be collected to monitor changes in the metabolome and gut microbial composition.

Conditions

Interventions

TypeNameDescription
OTHERprobiotic supplementation interventionprobiotic supplementation will be administered, while participants continue undergoing standard postoperative care
OTHERPlacebo supplementation interventionUndergo routine standard postoperative care with placebo intervention

Timeline

Start date
2026-03-19
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2026-03-27
Last updated
2026-03-27

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07497932. Inclusion in this directory is not an endorsement.